Filing Flows › Comparisons › DCOY vs BFRG
Decoy Therapeutics vs BullFrog AI Holdings: DCOY and BFRG compared
Decoy Therapeutics is the larger company: $228K of revenue in its latest quarter (Q2 2026) against $215K for BullFrog AI Holdings (Q2 2026).
Where the money goes: DCOY and BFRG
Decoy Therapeutics (DCOY) · Q2 2026
Decoy Therapeutics, Q2 2026: revenue $228K, net loss $2.4M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
BullFrog AI Holdings (BFRG) · Q2 2026
BullFrog AI Holdings, Q2 2026: revenue $215K (+548% year over year), operating margin -658.8%, net loss $1.4M, operating cash flow −$1.5M. The chart follows the revenue to costs, profit and cash.
| Decoy Therapeutics (DCOY) | BullFrog AI Holdings (BFRG) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $228K | $215K |
| Revenue growth, Y/Y | — | +548% |
| Operating margin | n/m | -658.8% |
| Net earnings | −$2.4M | −$1.4M |
| Net margin | — | -636.8% |
| Operating cash flow | −$2.7M | −$1.5M |
Questions
Which is bigger, Decoy Therapeutics or BullFrog AI Holdings?
Decoy Therapeutics is the larger company: $228K of revenue in its latest quarter (Q2 2026) against $215K for BullFrog AI Holdings (Q2 2026).
More: Decoy Therapeutics earnings · how Decoy Therapeutics makes money · BullFrog AI Holdings earnings · how BullFrog AI Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.